company
HealthPartners Neuroscience Center Research and Innovation
Industry: pharmaceutical
Jurisdiction: US
FDA Warning Letter timeline
V1 scope: FDA Warning Letters only. Additional public-record sources (SEC, CPSC, federal contracts) are on the V2 roadmap and are not surfaced here today.
- fda_warning_letter · warning_letter2026-05-19HealthPartners Neuroscience Center Research and Innovation — Good Laboratory Practice (GLP) for Nonclinical Laboratory Studies (2026-05-19)
Frequently asked questions
- How many FDA warning letters has HealthPartners Neuroscience Center Research and Innovation received?
- Argus HQ has recorded 1 FDA warning letter for HealthPartners Neuroscience Center Research and Innovation.
- What FDA recalls has HealthPartners Neuroscience Center Research and Innovation issued?
- Argus HQ has not recorded an FDA recall tied to HealthPartners Neuroscience Center Research and Innovation in our current dataset.
- Is HealthPartners Neuroscience Center Research and Innovation FDA compliant?
- Argus HQ is not a compliance rating service. As of this page's last update, our dataset shows 1 warning letter, 0 recalls, and 0 approval records for HealthPartners Neuroscience Center Research and Innovation. Review the linked FDA source records directly before drawing a compliance conclusion.
Informational only. FDA Warning Letters are public records (17 USC §105). Summaries are AI-assisted and may contain errors; always verify against the original FDA letter before acting. Not legal, financial, or regulatory advice.